- Report
- March 2026
- 168 Pages
Global
From €5220EUR$5,850USD£4,521GBP
- Report
- January 2026
- 187 Pages
Global
From €3164EUR$3,545USD£2,740GBP
€3515EUR$3,939USD£3,044GBP
- Report
- February 2026
- 250 Pages
Global
From €4007EUR$4,490USD£3,470GBP
- Report
- July 2024
- 120 Pages
Global
From €5310EUR$5,950USD£4,598GBP
- Report
- April 2023
- 119 Pages
Global
From €4016EUR$4,500USD£3,478GBP
- Report
- November 2025
- 132 Pages
Global
From €848EUR$950USD£734GBP
- Report
- November 2021
- 270 Pages
Global
From €2231EUR$2,500USD£1,932GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more